Collection
Myelodysplastic syndromes
Myelodysplastic syndromes (MDS) are hematological malignancies characterized by ineffective hematopoiesis and abnormal proliferation of blood...
- Status
- Open for submissions
- Submission deadline
- 31 December 2025
Overview
Annals of Hematology journal covers all the fields of hematology, from benign to oncological diseases, including clinical, biological, and experimental topics ranging from diagnosis to treatment of myeloid and lymphoid malignancies or rare disorders. Specific sections also covered are all aspects of:
- Transplantation
- Transfusion medicine
- Pediatric hematology
- Supportive care
- Editor-in-Chief
-
- Massimo Breccia
Societies and partnerships
Calls for papers
Latest articles
Journal updates
-
Annals of Hematology is now fully open access!
We are excited to announce that Annals of Hematology has now become a fully open access (OA) journal as of the 25th of January 2025; the journal’s first fully OA issue is February 2025 (Volume 104(2)). This means that we will only be publishing articles as Open Access meaning content will be and freely available to readers worldwide, enabling the widest possible dissemination and reuse.
Journal information
- Electronic ISSN
- 1432-0584
- Print ISSN
- 0939-5555
- Abstracted and indexed in
-
- AGRICOLA
- ANVUR
- BFI List
- BIOSIS
- Baidu
- Biological Abstracts
- CAB Abstracts
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Current Contents/Clinical Medicine
- Current Contents/Life Sciences
- Derwent Drug File
- Dimensions
- EBSCO
- EMBASE
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Medline
- Naver
- Norwegian Register for Scientific Journals and Series
- OCLC WorldCat Discovery Service
- Pathway Studio
- Portico
- ProQuest
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- Semantic Scholar
- TD Net Discovery Service
- Wanfang
- eLibrary.ru
© Springer-Verlag GmbH Germany, part of Springer Nature